𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Upregulation of interleukin-1 by Epstein–Barr virus latent membrane protein 1 and its possible role in nasopharyngeal carcinoma cell growth

✍ Scribed by Yu-Tzu Huang; Mei-Ying Liu; Ching-Hwa Tsai; Te-Huei Yeh


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
273 KB
Volume
32
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Nasopharyngeal carcinoma (NPC) is associated with Epstein–Barr virus (EBV) infection. We previously found that interleukin (IL)‐1α and IL‐1β significantly increased in NPC tissues. This study investigated what EBV‐encoded proteins were involved in such IL‐1 production.

Methods and Results

IL‐1α and IL‐1β messenger ribonucleic acids (mRNAs) were detected in the EBV latent membrane protein 1 (LMP1) transfectant (LMP135) only by reverse transcriptase–polymerase chain reaction (RT‐PCR). LMP1‐mediated IL‐1α and IL‐1β production could be enhanced by tumor necrosis factor alpha (TNF‐α), determined by enzyme‐linked immunosorbent assay (ELISA). Moreover, IL‐1α and IL‐1β mRNAs and proteins were increased in a dose‐dependent manner in epithelial cells transiently transfected by an LMP1 plasmid. Besides, immortalized human epidermal keratinocyte (RHEK‐1) epithelial cells could be enhanced to proliferate by IL‐1α and IL‐1β determined by water‐soluble tetrazolium salt (WST‐1) assay.

Conclusions

EBV LMP1 is capable of upregulating IL‐1α and IL‐1β secretions from epithelial cells and positively modulated by TNF‐α. This may consequently contribute to tumor growth in patients with NPC. © 2009 Wiley Periodicals, Inc. Head Neck, 2009


📜 SIMILAR VOLUMES


Latent membrane protein-1 of Epstein-Bar
✍ Yu Liu; Xianghong Wang; Angela K.F. Lo; Yong Chuan Wong; Annie L.M. Cheung; Sai 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Abstract Nasopharyngeal carcinoma is closely associated with Epstein‐Barr virus (EBV) and the EBV encoded latent membrane protein‐1 expression (LMP1) is commonly found in the tumour cells. LMP1 has been shown to be involved in modulation of cell growth in B cells but the biological properties of

Specific latent membrane protein 1 gene
✍ Siu-Tim Cheung; Sing-Fai Leung; Kwok-Wai Lo; K. W. Chiu; J. S. L. Tam; T. F. Fok 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 116 KB 👁 2 views

We reported previously that a characteristic Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) gene was associated with nasopharyngeal carcinoma (NPC) in Hong Kong. It showed a 30 bp deletion at the carboxyl terminus with specific amino acid substitution Asp at codon 335 with reference to Gly

Latent membrane protein 1 of Epstein–Bar
✍ Chan-Hee Park; Hak-Ryul Kim; Ju Kim; Sun-Hee Jang; Kyung-Yeol Lee; Gook-Hyun Chu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

## Abstract We have previously shown that SNU‐1103, which is a latency type III Epstein–Barr virus (EBV)‐transformed lymphoblastoid cell line (LCL) that was developed from a Korean cancer patient, resists serum starvation‐induced G~1~ arrest. In this study, we examined the role of latent membrane p

Analyses of Epstein-Barr virus latent me
✍ Eng-Lai Tan; Suat-Cheng Peh; Choon-Kook Sam 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

## Abstract Nasopharyngeal carcinoma, a malignancy associated closely with Epstein‐Barr virus (EBV), is prevalent among Chinese of Southern China origin. Epidemiological studies indicate a high prevalence of EBV in Asia with viral isolates having typical characteristics of the putative viral oncoge

High frequency of latent membrane protei
✍ Rkia Dardari; Meriem Khyatti; Paulo Cordeiro; Mohieddine Odda; Brahim ElGueddari 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 412 KB 👁 1 views

## Abstract Latent membrane protein 1 (LMP‐1) is an Epstein‐Barr virus‐encoded oncoprotein expressed in ∼50–70% of nasopharyngeal carcinoma (NPC). Previous studies have shown that NPC‐derived LMP‐1 variants carrying 30 bp deletion and specific mutations in the 3′C‐terminal region confer high oncoge